Mukka Proteins Ltd
Incorporated in 2003, Mukka Proteins
Ltd is a manufacturer and exporter
of Fish Meal and Fish oil[1]
- Market Cap ₹ 692 Cr.
- Current Price ₹ 23.1
- High / Low ₹ 31.2 / 18.3
- Stock P/E 13.3
- Book Value ₹ 16.6
- Dividend Yield 0.00 %
- ROCE 11.6 %
- ROE 11.1 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
- Company's working capital requirements have reduced from 63.0 days to 45.2 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Food Products Animal Feed
Part of BSE Fast Moving Consumer Goods
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| 409 | 549 | 604 | 770 | 1,177 | 1,380 | 1,006 | 1,449 | |
| 385 | 525 | 582 | 723 | 1,091 | 1,274 | 912 | 1,335 | |
| Operating Profit | 23 | 24 | 22 | 48 | 86 | 105 | 95 | 115 |
| OPM % | 6% | 4% | 4% | 6% | 7% | 8% | 9% | 8% |
| 2 | 8 | 10 | 7 | 8 | 19 | 16 | 31 | |
| Interest | 4 | 7 | 8 | 10 | 16 | 25 | 37 | 54 |
| Depreciation | 2 | 5 | 8 | 9 | 12 | 12 | 14 | 17 |
| Profit before tax | 19 | 20 | 15 | 36 | 66 | 87 | 60 | 75 |
| Tax % | 27% | 31% | 29% | 28% | 28% | 15% | 20% | 24% |
| 14 | 14 | 11 | 26 | 48 | 74 | 48 | 57 | |
| EPS in Rs | 1.10 | 2.00 | 2.34 | 1.55 | 1.74 | |||
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 7% |
| TTM: | 44% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 53% |
| 3 Years: | 6% |
| TTM: | 12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -23% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 15% |
| Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 22 | 22 | 30 | 30 | 30 |
| Reserves | 38 | 51 | 61 | 76 | 126 | 366 | 411 | 469 |
| 83 | 142 | 159 | 175 | 262 | 365 | 453 | 779 | |
| 74 | 95 | 129 | 119 | 166 | 179 | 183 | 343 | |
| Total Liabilities | 201 | 293 | 355 | 392 | 575 | 941 | 1,076 | 1,621 |
| 49 | 78 | 79 | 83 | 85 | 85 | 94 | 194 | |
| CWIP | -0 | 2 | 4 | -0 | -0 | -0 | 9 | 30 |
| Investments | 8 | 4 | 12 | 21 | 21 | 31 | 37 | 56 |
| 144 | 209 | 260 | 289 | 469 | 825 | 937 | 1,341 | |
| Total Assets | 201 | 293 | 355 | 392 | 575 | 941 | 1,076 | 1,621 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| -20 | -25 | 2 | 5 | -56 | -150 | -112 | -111 | |
| -23 | -28 | -14 | -11 | -3 | -48 | -35 | -146 | |
| 34 | 54 | 13 | 15 | 75 | 266 | 56 | 267 | |
| Net Cash Flow | -9 | 1 | 2 | 8 | 15 | 68 | -91 | 10 |
| Free Cash Flow | -39 | -61 | -8 | -1 | -64 | -165 | -137 | -248 |
| CFO/OP | -67% | -81% | 29% | 22% | -52% | -118% | -114% | -84% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 25 | 23 | 29 | 29 | 35 | 49 | 72 | 46 |
| Inventory Days | 95 | 89 | 106 | 95 | 89 | 136 | 266 | 267 |
| Days Payable | 63 | 63 | 71 | 56 | 51 | 44 | 67 | 75 |
| Cash Conversion Cycle | 57 | 49 | 64 | 68 | 73 | 141 | 272 | 238 |
| Working Capital Days | 4 | -9 | -12 | -1 | 10 | 45 | 99 | 45 |
| ROCE % | 15% | 9% | 18% | 24% | 19% | 12% | 12% |
Insights
In beta| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Export Revenue Share % |
|
|||||
| Number of Customers Served count |
||||||
| Fish Meal Capacity Utilization % |
||||||
| Fish Meal Installed Capacity MT/year |
||||||
| Fish Meal Production Volume MT |
||||||
| Fish Oil Production Volume MT |
||||||
| Top 10 Customer Concentration % |
||||||
| Insect Protein Wet Waste Processed Tons |
||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
2d - Mukka Proteins entered a 5-year unsecured loan agreement up to Rs. 9.1 crore with subsidiary United Gulf Fishery Products LLC on 9 July 2026.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
2d - Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June 2026.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
7 Jul - Intimation on Newspaper publication of Corrigendum to the notice of Postal Ballot dated June 12, 2026.
- Intimation Regarding Issuance Of Corrigendum To The Notice Of Postal Ballot. 6 Jul
-
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015.
1 Jul - CIT(A) order dated 30 Jun 2026 partly allowed AY2018-19 appeal; ₹7.54 crore addition sustained, ₹7.08 crore relief.
Business Overview:[1]
MPL manufactures Fish Protein products and supplies fish meal, fish oil and fish soluble paste
which is an essential ingredient in manufacturing of aqua feed (for fish and shrimp), poultry feed (for broiler and layer) and pet food (dog and cat food). Further, fish oil also finds application in pharmaceutical products (Omega-3 pills and related products derived from fish oil), soap manufacturing, leather tanneries and paint industries